Inflammatory myopathies

Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease

RMD OpenPublished Secondary analysis of the Abatacept in Myositis-Associated Interstitial Lung Disease trial

Authors' conclusion

Longitudinal QIA scores associate with lung physiology, patient perception of respiratory status, overall disease activity and quality of life over time in ARS-ILD.

Study context

Population
Patients with antisynthetase antibodies and active ILD (ASyS-ILD); median age 57 years, 55% males, 85% white
Participants
20 patients
Primary endpoint
Association between extent of CT abnormalities by QIA (ground glass, QLF, QILD) and clinical/physiological disease parameters
Follow-up
Weeks 0, 24 and 48
Methodological detailslongitudinal, repeated-measures mixed-effects models
  • Longitudinal
  • Repeated-measures mixed-effects models

Primary result

As reported in the abstract

QIA scores vs clinical/physiological parameters
  • Higher (worse) baseline quantitative imaging analysis (QIA) scores correlated with lower baseline forced vital capacity (FVC) and DLCO
  • Longitudinal QIA scores strongly associated with both FVC and DLCO over time
  • Higher QILD scores over time associated with worse dyspnoea scores, pulmonary VAS, physician and patient global disease activity, health status in 6/8 SF-36 domains and higher oxygen requirements

Further findings

Longitudinal QIA trajectories

Trended towards improving scores during the trial; patients on O2 at baseline had worsening trajectories, different from those not on O2

Significant radiographic improvement · 48 weeks

Patients with significant radiographic improvement had higher baseline QLF, QILD and worse DLCO

Original publication

Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease. RMD Open. Published 27 November 2024. doi:10.1136/rmdopen-2024-004592

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.